India’s Rare-Disease Drug Sector: Turning Pharma Strength into Affordable Innovation
India’s Rare-Disease Drug Sector: Turning Pharma Strength into Affordable Innovation Context India’s pharmaceutical capabilities and large, diverse patient population create









